Department of Virology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Department of Virology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.
Int J Mol Sci. 2024 Mar 20;25(6):3523. doi: 10.3390/ijms25063523.
Borna disease virus (BoDV-1) is a bornavirus that infects the central nervous systems of various animal species, including humans, and causes fatal encephalitis. BoDV-1 also establishes persistent infection in neuronal cells and causes neurobehavioral abnormalities. Once neuronal cells or normal neural networks are lost by BoDV-1 infection, it is difficult to regenerate damaged neural networks. Therefore, the development of efficient anti-BoDV-1 treatments is important to improve the outcomes of the infection. Recently, one of the clustered regularly interspaced short palindromic repeats (CRISPRs) and CRISPR-associated (Cas) systems, CRISPR/Cas13, has been utilized as antiviral tools. However, it is still unrevealed whether the CRISPR/Cas13 system can suppress RNA viruses in persistently infected cells. In this study, we addressed this question using persistently BoDV-1-infected cells. The CRISPR/Cas13 system targeting viral mRNAs efficiently decreased the levels of target viral mRNAs and genomic RNA (gRNA) in persistently infected cells. Furthermore, the CRISPR/Cas13 system targeting viral mRNAs also suppressed BoDV-1 infection if the system was introduced prior to the infection. Collectively, we demonstrated that the CRISPR/Cas13 system can suppress BoDV-1 in both acute and persistent infections. Our findings will open the avenue to treat prolonged infection with RNA viruses using the CRISPR/Cas13 system.
博尔纳病病毒(BoDV-1)是一种能够感染包括人类在内的多种动物中枢神经系统的博尔纳病毒,可导致致命性脑炎。BoDV-1 还可在神经元细胞中建立持续性感染,并引起神经行为异常。一旦神经元细胞或正常神经网络因 BoDV-1 感染而丢失,受损神经网络的再生就变得十分困难。因此,开发有效的抗 BoDV-1 治疗方法对于改善感染的预后非常重要。最近,一种成簇规律间隔短回文重复序列(CRISPRs)和 CRISPR 相关(Cas)系统,CRISPR/Cas13,已被用作抗病毒工具。然而,CRISPR/Cas13 系统是否能抑制持续性感染细胞中的 RNA 病毒仍未可知。在本研究中,我们使用持续性 BoDV-1 感染的细胞来回答这个问题。靶向病毒 mRNA 的 CRISPR/Cas13 系统可有效降低持续性感染细胞中靶病毒 mRNA 和基因组 RNA(gRNA)的水平。此外,如果在感染之前引入靶向病毒 mRNA 的 CRISPR/Cas13 系统,该系统还能抑制 BoDV-1 感染。总之,我们证明了 CRISPR/Cas13 系统可以抑制急性和持续性感染中的 BoDV-1。我们的研究结果将为使用 CRISPR/Cas13 系统治疗 RNA 病毒的持续性感染开辟新的途径。